Features of immunophenotype of pancreatic ductal adenocarcinoma

Features of immunophenotype of pancreatic ductal adenocarcinoma

Aim. To determine features of immunophenotype of pancreatic ductal adenocarcinoma. Methods and results. At the immunohistochemical research of biopsy and postoperative material of 120 patients with pancreatic ductal adenocarcinoma the expression levels of diagnostic markers of ductal-genesis canc...

Full description

Saved in:

Bibliographic Details
Main Author:	A. V. Evseyev
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2014-12-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	Pancreatic Cancer Immunohistochemistry
Online Access:	http://zmj.zsmu.edu.ua/article/view/35867/32109
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunohistochemical Evaluation of the Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Gelu Mihai Breaza, et al.
Published: (2025-03-01)

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2015-08-01)

Pathomorphological description of proliferation and apoptosis processes in pancreatic intraepithelial neoplasia in the pancreatic ductal adenocarcinoma and chronic pancreatitis
by: V. A. Tumanskiy, et al.
Published: (2014-08-01)

Comparative estimation of ErbB family growth receptors, Ki-67 and E-cadherin expression in pancreatic ductal adenocarcinoma cells
by: V. A. Tumanskiy, et al.
Published: (2014-12-01)

Administration of aspirin and risk of pancreatic ductal adenocarcinoma
by: Arooba Noor Abbasi, et al.
Published: (2024-12-01)

Lack of association between SLFN11 expression and treatment efficacy or survival outcomes in patients with pancreatic ductal adenocarcinoma
by: Takeaki Nakamura, et al.
Published: (2025-05-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01)

The Role of Resolvin D1 in the Differential Diagnosis of Pancreatic Ductal Adenocarcinoma and Acute Pancreatitis: A Case-Control Study
by: Yasemin Pekmezci, et al.
Published: (2025-01-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01)

Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
by: Chelsae R. Watters, et al.
Published: (2025-03-01)

Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma
by: Zachary Kaplan, et al.
Published: (2025-05-01)

Immunohistochemical characteristics of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma
by: M. A. Shyshkin, et al.
Published: (2024-04-01)

Nanocarriers for Combination Therapy in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review
by: Iris Pontón, et al.
Published: (2025-07-01)

Consensus statement on the use of systemic therapies in pancreatic ductal adenocarcinoma in Asia
by: D.-Y. Oh, et al.
Published: (2025-06-01)

Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report
by: Seiji Nakahara, et al.
Published: (2023-08-01)

KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma
by: Mahmoud Yousef, et al.
Published: (2025-04-01)

Cancer stem cells and mesenchymal stem cells in pancreatic ductal adenocarcinoma
by: V. O. Tumanskyi, et al.
Published: (2019-06-01)

A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
by: Bo Li, et al.
Published: (2025-02-01)

Mechanistic insights and therapeutic strategies for targeting autophagy in pancreatic ductal adenocarcinoma
by: Federica Michetti, et al.
Published: (2025-04-01)

Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)

Claudin 18 (43–14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy
by: Riley J. Arseneau, et al.
Published: (2025-05-01)

Contribution of gut microbiome to pancreatic ductal adenocarcinoma development
by: D. V. Zaitsev, et al.
Published: (2025-05-01)

Targeting myeloid cells in pancreatic ductal adenocarcinoma: from primary tumors to liver metastasis
by: Ruining Gong, et al.
Published: (2025-05-01)

Tumor-associated macrophages (TAMs): Constructing an immunosuppressive microenvironment bridge for pancreatic ductal adenocarcinoma (PDAC)
by: Runjie Liu, et al.
Published: (2025-05-01)

Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment
by: Yuxi Qiao, et al.
Published: (2025-08-01)

Identifying Hub Genes and Pathways in Pancreatic Ductal Adenocarcinoma (PAAD): A comprehensive in silico study
by: Elham Karimi, et al.
Published: (2025-03-01)

Combination of imaging features on pancreatic CT for predicting early recurrence after upfront pancreatoduodenectomy of pancreatic ductal adenocarcinoma
by: Shuanglin Zhang, et al.
Published: (2025-12-01)

Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma
by: Shuntaro Tsukamoto, et al.
Published: (2025-05-01)

Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study
by: Ritu R. Singh, et al.
Published: (2023-02-01)

Clinical application of combined CT radiomics and clinical features in survival prediction for pancreatic ductal adenocarcinoma patients
by: LI Ke, et al.
Published: (2025-07-01)

Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasms of the Pancreas
by: William A. Ziaziaris, et al.
Published: (2024-12-01)

Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma
by: Remya P. G. Ramesh, et al.
Published: (2025-03-01)

Survival benefit of adjuvant therapy completion with early initiation for patients with pancreatic ductal adenocarcinoma
by: Kenjiro Okada, et al.
Published: (2025-07-01)

PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
by: Abul Azad, et al.
Published: (2016-12-01)

Preoperative prediction for early recurrence in patients with pancreatic ductal adenocarcinoma: combining radiomics and abdominal fat analysis
by: Suo Yu Yan, et al.
Published: (2025-07-01)

Differentiating localized autoimmune pancreatitis and pancreatic ductal adenocarcinoma using endoscopic ultrasound images with deep learning
by: Hitomi Nakamura, et al.
Published: (2024-04-01)

Effective Extracellular Volume Fraction Determined by Equilibrium Contrast-Enhanced CT for Differentiating Autoimmune Pancreatitis from Pancreatic Ductal Adenocarcinoma
by: Akihiko Kanki, et al.
Published: (2025-07-01)

The Clonal Trajectory of Liver and Lung Metastases in Pancreatic Ductal Adenocarcinoma
by: Ofer N. Gofrit, et al.
Published: (2025-05-01)

HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression
by: Aiat Shaban Hemida, et al.
Published: (2024-10-01)

Prognostic significance of serum MUC5AC in resected pancreatic ductal adenocarcinoma: initial insights
by: Ashish Manne, et al.
Published: (2025-04-01)